AzTrials
AzTrials

Analgesia, EpiduralPhase 4NCT06889285

Comparison of Safety and Efficacy Between PIEB and CEI for Labour Epidural Analgesia

A Phase 4 study testing Continuos epidural infusion and Programmed intermittent epidural bolus in people with Analgesia, Epidural, run by Hospital Universiti Sains Malaysia at 1 site in Malaysia.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to compare safety and efficacy of programmed intermittent epidural bolus (PEIB) and continuous epidural infusion (CEI) in parturients during active phase of labour. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Analgesia, Epidural
What is being tested?
Continuos epidural infusion and Programmed intermittent epidural bolus
Could I receive a placebo?
No, everyone receives an active treatment
How many people
76 participants
Where
1 siteMalaysia
Study dates
1 Apr 2025to 30 Dec 2025
Phase
Phase 4
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • age > 18 years old
  • ASA 2 \& 3w

Who cannot join

  • patient refusal
  • significant comorbiddities, eg patient with heart disease, kidney diseae, neurological disoder
  • contraindicated to neuraxial blockade
  • allergic to local anesthetic agent or opioid
  • obstetric complications, eg pre-eclampsia, leaking liqour, suspicious CTG
  • morbid obesity, BMI > 40
Show all 9Show fewer
  • grandmultiparous ( > 5biths at > 20 weeks gestation)
  • combined spinal epidural technique for labour epidural analgesia
  • height < 145cm

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Dr Koeh Shao Keong, Doctor of Medicine contact

+60169686388

keong705@gmail.com

Malaysia1 site
  • Hospital Pakar Universiti Sains Malaysia

    Kubang Kerian, Kelantan, 16150

Other trials in Malaysia

About this study

Official title: Comparison of Safety and Efficacy Between Programmed Intermittent Epidural Bolus (PIEB) and Continuous Epidural Infusion (CEI) for Labour Epidural Analgesia: a Randomized Controlled Trial

The goal of this clinical trial is to compare safety and efficacy of programmed intermittent epidural bolus (PEIB) and continuous epidural infusion (CEI) in parturients during active phase of labour.

The main questions aimed to answer are:

Read more
  • Will parturient using PIEB+PCEA has lower incidence of motor block as compared to CEI during labour?
  • Will parturient using PIEB + PCEA has lower local anaesthetic consumption (in mg/hr) as compared to CEI during labour?
  • Will parturient using PIEB + PCEA has shorter duration of second stage labour as compared to CEI?
  • Will parturient using PIEB + PCEA has better satisfaction score when compared to CEI during labour?

Participants will be randomised into PIEB group and CEI group after informed consent taken

  • All participants will be taken baseline demographic data, vital signs, Bromage score, cardiotocograph prior intervention
  • Labour epidural will be inserted and started on PIEB protocol or CEI protocol based on randomisation
  • Participants vital signs and Bromage score will be recorded hourly till baby delivery
  • In the end of delivery, total LA consumption and duration of second stage will be recorded
  • Within 24 hours, participants will be interviewed on their satisfaction score on labour epidural analgesia.

Researchers will compare PIEB and CEI to see if PIEB has better safety and efficacy as compared to CEI in labour epidural analgesia.

Read the detailed description

Parturient attending to labour room in Hospital Universiti Sains Malaysia and requested for labour epidural analgesia will be screened and recruited into this clinical trial. Before participation, an informed consent will be taken from parturient.

PIEB + PCEA or CEI will be used on recruited participants based on the randomised group by primary investigator. Setup of epidural cocktail infusion pump either CADD-Solis ® pump or normal infusion pump, will be done by anaesthetic officer attending the patient.

For PIEB group, ropivacaine 0.05% + fentanyl 2mcg/ml in 100ml bag will be used for epidural analgesia. For CEI group, bupivacaine 0.1% + fentanyl 2mcg.ml in 50ml will be used for epidural analgesia. Both epidural cocktails are prepared by central pharmacist in sterile technique. Participants, researcher and the anaesthetist-in-charge can't be blinded from the study in view the CADD-Solis ® pump is unique with its PCEA bolus cord.

Prior procedure, participants baseline pain score, CTG, vital signs, Bromage score will be recorded prior to epidural catheter insertion. If CTG and vital signs are reassuring, then only anaesthetist-in-charge will proceed with epidural catheter insertion.

There will be assigned two groups of patients receiving different epidural regimen;

  1. PIEB + PCEA group

This group patient will be inserted epidural catheter at L3/L4 or L4/L5 depending on anaesthetist-in-charge justification, epidural catheter will be kept 4-5 cm in epidural space and anchored with adhesive tape. A test dose of LA Lignocaine 2% 2ml will be given after epidural insertion. CADD-Solis infusion tubing will be primed in advance. Epidural catheter will be connected to epidural cocktail (Ropivacaine 0.05% + Fentanyl 2mcg/ml in 100ml mixture) with the protocol as below:

  • Loading dose: 10ml
  • Intermittent bolus: 10ml, bolus interval 1 hour, next bolus 1 hour
  • PCEA dose: 10ml, lockout interval 10 minutes

II. CEI group This group of parturient will be inserted epidural catheter at L3/L4 or L4/L5 depending on anaesthetist-in-charge justification, epidural catheter will be kept 4-5 cm in epidural space and anchored with adhesive tape. Similarly, a test dose of LA Lignocaine 2% 2ml will be given after epidural insertion. Infusion tubing will be primed in advance. Epidural catheter will be connected to epidural cocktail (Bupivacaine 0.1% + Fentanyl 2mcg/ml in 50ml mixture) with the protocol as below: (directly extracted from Malaysia Pain management in Obstetrics and Gynaecology Procedure Guideline 2023)

  • Loading dose 10 ml
  • Continuous infusion: 10ml/hour

During epidural catheter insertion, inadvertent spinal catheterisation or dura puncture will be reported and manged to clinician justification, meanwhile patient will be withdrawn from this study.

Participant's CTG will be recorded after epidural catheterisation. After started on epidural analgesia, participants blood pressure will be recorded every 5 mins in first 30 mins, every 15 mins for another 30 mins, then every hourly subsequently. Participants' pain score will be recorded 15 mins after epidural analgesia started, then hourly recording of pain score using Visual Analogue Scale. Similarly, Bromage score will be recorded hourly by attending labour room nurse. This monitoring follows USM epidural analgesia monitoring protocol.

Any breakthrough pain requiring physician rescue will be attended by anaesthetist-in- charge, dose and amount of local anaesthetic agent given, time of breakthrough pain will be recorded in data collection sheet. If participants have unresolved labour pain despite physician rescue bolus of drug and unable to achieve pain score of < 3, the catheter will be deemed ineffective, and the participant will be removed from the study.

Any adverse event, such as pruritus, nausea vomiting, maternal hypotension or high block will be recorded if applicable. In the end of delivery, the CADD-Solis pump/Infusion pump will be examined for total consumption of epidural cocktail in ml, its average hourly consumption, number of patient's self-administered PCEA bolus.

Obstetric and neonatal outcome, such as mode of delivery, indication for instrumental or Caesarean delivery, duration of second stage of labour and neonatal Apgar score at 1 and 5 mins will be documented in data collection sheet. The parturient will be interviewed within 24 hours of delivery by a different anaesthetist not involved in the study for overall assessment of her satisfaction with labour analgesia (graded on verbal scale from 0 = very dissatisfied to 100 = extremely satisfied)

Being tested
Continuos epidural infusion, Programmed intermittent epidural bolus
Medical subject headings
Agnosia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Continuos epidural infusionProcedure or surgery

    This group of parturient will be inserted epidural catheter at L3/L4 or L4/L5 depending on anaesthetist-in-charge justification, epidural catheter will be kept 4-5 cm in epidural space and anchored with adhesive tape. Similarly, a test dose of LA Lignocaine 2% 2ml will be given after epidural insertion. Infusion tubing will be primed in advance. Epidural catheter will be connected to epidural cocktail (Bupivacaine 0.1% + Fentanyl 2mcg/ml in 50ml mixture) with the protocol as below: (directly extracted from Malaysia Pain management in Obstetrics and Gynaecology Procedure Guideline 2023)

    • Loading dose 10 ml
    • Continuous infusion: 10ml/hour
  • Programmed intermittent epidural bolusProcedure or surgery

    This group patient will be inserted epidural catheter at L3/L4 or L4/L5 depending on anaesthetist-in-charge justification, epidural catheter will be kept 4-5 cm in epidural space and anchored with adhesive tape. A test dose of LA Lignocaine 2% 2ml will be given after epidural insertion. CADD-Solis infusion tubing will be primed in advance. Epidural catheter will be connected to epidural cocktail (Ropivacaine 0.05% + Fentanyl 2mcg/ml in 100ml mixture) with the protocol as below:

    • Loading dose: 10ml
    • Intermittent bolus: 10ml, bolus interval 1 hour, next bolus 1 hour
    • PCEA dose: 10ml, lockout interval 10 minutes
Study groups in NCT06889285
Study groupRoleWhat they receive
Continuous Epidural AnalgesiaExperimentalEpidural catheter will be connected to epidural cocktail (Bupivacaine 0.1% + Fentanyl 2mcg/ml in 50ml mixture) with the protocol as below: (directly extracted from Malaysia Pain management in Obstetrics and Gynaecology Procedure Guideline 2023) * Loading dose 10 ml * Continuous infusion: 10ml/hour
Receives: Procedure: Continuos epidural infusion
Programmed Intermittent Epidural BolusExperimentalPatient in this group receive programmed intermittent epidural bolus (PIEB) using cocktail of Ropivacaine 0.05% + fentanyl 2mcg/ml, with 10ml cocktail loading when started, then 10ml hourly bolus, with patient controlled epidural analgesia (PCEA) - 10ml per patient request, lockout interval 10minutes.
Receives: Procedure: Programmed intermittent epidural bolus

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. To compare the incidence of motor block during labour between parturient with PIEB + PCEA and those with CEI.

    Bromage score is measured hourly after epidural insertion. If there is any time when Bromage is greater than 0, then will be considered presence of motor block.

    Measured: 1 year

Secondary outcomes (3)
  1. To compare the duration of second stage labour between parturient with PIEB+CEA and those with CEI.

    • From patient partogram, we will calculate duration of second stage labour for each patient (from cervical os 10cm till delivery of baby)

    Measured: 1 year

  2. To compare the local anaesthetic consumption (in mg/hr) during labour between parturient with PIEB + PCEA and those with CEI

    For PIEB+ PCEA group, the LA consumption will be retrieved from CADD-Solis pump which record total of LA use and number of patient's requested bolus. As for CEI group, its consumption can be derived from amount of LA given in the syringe and manual record where amount of physician bolus given.

    Measured: 1 year

  3. To compare the satisfaction score during labour between parturient with PIEB+PCEA and those with CEI

    Within 24 hours after delivery, parturient will be interviewed on the satisfaction score on the epidural regimen given with numerical rating scale from 0 to 100, where 0 is most unsatisfied and 100 is most satisfied.

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Mar 2025
  2. Study start1 Apr 2025 (estimated)
  3. Primary completion30 Aug 2025 (estimated)
  4. Study completion30 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
76 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06889285
Sponsor's protocol ID
USM/JEPeM/KK/23110826
Status last verified
Mar 2025
First submitted
15 Mar 2025
Last updated
21 Mar 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Continuos epidural infusion and Programmed intermittent epidural bolus in people with Analgesia, Epidural, run by Hospital Universiti Sains Malaysia at 1 site in Malaysia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 21 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Malaysia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Dr Koeh Shao Keong, Doctor of Medicine (+60169686388, keong705@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

To compare the incidence of motor block during labour between parturient with PIEB + PCEA and those with CEI. (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in